Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
300 participants
INTERVENTIONAL
2023-03-21
2033-03-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Westlake Precision Birth Cohort
NCT04060056
Medical Nutrition Therapy Intervention Program for Women With Gestational Diabetes--a Prospective Study
NCT02893072
Diagnostic Analysis of Oral Glucose Tolerance Test in Early Pregnancy for Gestational Diabetes Mellitus
NCT05487352
Construction and Biological Study of Blood and Placenta Samples Associated With Gestational Diabetes Mellitus
NCT05148130
Gestational Lifestyle & Outcomes Wellness
NCT07263412
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standardized breakfast
Egg (50g), whole-wheat bread (35g), celery (30g), and dried bean curd (10g)
Standardized breakfast
Participants will be provided with a standardized breakfast on a morning of the days they wear a continuous glucose monitoring (CGM) device.
Standardized snack
Tomato (50g) and skim milk (200g)
Standardized snack
Participants will be provided with a standardized snack 2 hour after they have the standardized breakfast.
Standardized lunch
Rice (40g), oats (40g), shrimp (70g), lettuce (80g), lean pork (30g), carrot (10g), soaked auricularia auricula (20g), broccoli (80g), cucumber (10g), tomato egg drop soup (200g), salt (3g), and oil (8g)
Standardized lunch
Participants will be provided with a standardized lunch 2 h after they have the standardized snack.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standardized breakfast
Participants will be provided with a standardized breakfast on a morning of the days they wear a continuous glucose monitoring (CGM) device.
Standardized snack
Participants will be provided with a standardized snack 2 hour after they have the standardized breakfast.
Standardized lunch
Participants will be provided with a standardized lunch 2 h after they have the standardized snack.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women with GDM mainly at 24-28 weeks of gestation
* Women intended to deliver at Wenzhou People's Hospital
* Women intended to remain in Wenzhou with their child for ≥4 years
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wenzhou People's Hospital
OTHER
Westlake University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ju-Sheng Zheng, PhD
Role: PRINCIPAL_INVESTIGATOR
Westlake University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wenzhou People's Hospital
Wenzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20221213ZJS001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.